Somatostatin receptor 4

SSTR4
Identifiers
AliasesSSTR4, SS-4-R, SS4-R, SS4R, Somatostatin receptor 4
External IDsOMIM: 182454; MGI: 105372; GeneCards: SSTR4
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez

6754

20608

Ensembl

ENSG00000132671

ENSMUSG00000037014

UniProt

P31391

P49660

RefSeq (mRNA)

NM_001052

NM_009219

RefSeq (protein)

NP_001043

NP_033245

Location (UCSC)Chr 20: 23.04 – 23.04 MbChr 2: 148.24 – 148.24 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Somatostatin receptor type 4 is a protein that in humans is encoded by the SSTR4 gene.[5][6]

Function

Somatostatin acts at many sites to inhibit the release of many hormones and other secretory proteins. The biologic effects of somatostatin are probably mediated by a family of G protein-coupled receptors that are expressed in a tissue-specific manner. SSTR4 is a member of the superfamily of receptors having seven transmembrane segments and is expressed in highest levels in fetal and adult brain and lung.[6]

Ligands

Agonists

See also

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000132671 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000037014 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ↑ Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schüle R (May 1993). "Cloning and characterization of a fourth human somatostatin receptor". Proceedings of the National Academy of Sciences of the United States of America. 90 (9): 4196–4200. Bibcode:1993PNAS...90.4196R. doi:10.1073/pnas.90.9.4196. PMC 46473. PMID 8483934.
  6. 1 2 "Entrez Gene: SSTR4 somatostatin receptor 4".
  7. ↑ Engström M, Tomperi J, El-Darwish K, Ahman M, Savola JM, Wurster S (January 2005). "Superagonism at the human somatostatin receptor subtype 4". The Journal of Pharmacology and Experimental Therapeutics. 312 (1): 332–338. doi:10.1124/jpet.104.075531. PMID 15333679.
  8. ↑ Moneta D, Richichi C, Aliprandi M, Dournaud P, Dutar P, Billard JM, et al. (September 2002). "Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice". The European Journal of Neuroscience. 16 (5): 843–849. doi:10.1046/j.1460-9568.2002.02146.x. PMID 12372020.
  9. ↑ Borbély É, Pethő G (August 2024). "Drug effects on neuropeptides and their receptors: Big hopes but moderate success in the treatment of chronic pain". Current Opinion in Pharmacology. 77 102474. doi:10.1016/j.coph.2024.102474. PMID 39121555.
  10. ↑ Sandoval KE, Farr SA, Banks WA, Crider AM, Morley JE, Witt KA (15 May 2012). "Somatostatin receptor subtype-4 agonist NNC 26-9100 decreases extracellular and intracellular Aβ1-42 trimers". European Journal of Pharmacology. 683 (1–3): 116–124. doi:10.1016/j.ejphar.2012.03.020. PMC 3340534. PMID 22449380.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.